期刊文献+
共找到7篇文章
< 1 >
每页显示 20 50 100
Synthesis and biological evaluation of andrographolide derivatives as potent anti-HIV agents 被引量:2
1
作者 Bin Wang Jing Li +3 位作者 Wen Long Huang Hui Bin Zhang Hai Qian Yong Tang Zheng 《Chinese Chemical Letters》 SCIE CAS CSCD 2011年第7期781-784,共4页
一系列 Andro 衍生物在 vitro 为他们的 anti-HIV 活动被描述并且评估。化合物 10 并且 16b, TI 是 > 10,在 vitro 举办了某 anti-HIV-1 活动。在那里,加重 10 它是最好的有势力混合物,能为反爱滋病代理人的进一步的开发担任新... 一系列 Andro 衍生物在 vitro 为他们的 anti-HIV 活动被描述并且评估。化合物 10 并且 16b, TI 是 > 10,在 vitro 举办了某 anti-HIV-1 活动。在那里,加重 10 它是最好的有势力混合物,能为反爱滋病代理人的进一步的开发担任新领先。 展开更多
关键词 抗艾滋病毒 穿心莲内酯 生物评价 衍生物 毒药 合成 抗艾滋病药物 化合物
原文传递
Identification of the novel N-phenylbenzenesulfonamide derivatives as potent HIV inhibitors 被引量:2
2
作者 Yong Sun Cui-Lin Lu +8 位作者 Chang-Yuan Wang Rui-Rui Wang Ke-Xin Liu Liu-Meng Yang Yu-Hong Zhen Hou-Li Zhang Chao Wang Yong-Tang Zheng Xiao-Dong Ma 《Chinese Chemical Letters》 SCIE CAS CSCD 2015年第2期243-247,共5页
Searching for more safe and effective agents for HIV treatments is still an urgent topic worldwide.Based on our continuous modifications on the benzophenone derivatives as HIV-1 reverse transcriptase(RT)inhibitors,a... Searching for more safe and effective agents for HIV treatments is still an urgent topic worldwide.Based on our continuous modifications on the benzophenone derivatives as HIV-1 reverse transcriptase(RT)inhibitors,a new template bearing N-phenylbenzenesulfonamide(PBSA) structure was designed to enhance the interactions with HIV-1 RT.In this manuscript,a series of PBSA derivatives were synthesized and evaluated for their anti-HIV-1 activity.The preliminary test showed that these compounds were potent to inhibit wild-type HIV-1 with EC_(50) values ranging of 0.105-14.531 μmol/L.In particular,compound 13 f not only has high anti-HIV-1 activity(0.108 μmol/L),but also possesses low toxicity with a Tl value of 1816.6.Furthermore,the major interactions of the inhibitor 13 f with HIV-1 RT were also investigated using the molecular modelling.Our discovered structure-activity relationships(SARs) of these analogues may serve as an important clue for further optimizations. 展开更多
关键词 Benzophenone N-Phenylbenzenesulfonamide Structure modification Anti-HIV activity
原文传递
Antimicrobial peptides: new hope in the war against multidrug resistance 被引量:25
3
作者 James Mwangi Xue Hao +1 位作者 Ren Lai Zhi-Ye Zhang 《Zoological Research》 SCIE CAS CSCD 2019年第6期488-505,共18页
The discovery of antibiotics marked a golden age in the revolution of human medicine. However,decades later, bacterial infections remain a global healthcare threat, and a return to the pre-antibiotic era seems inevita... The discovery of antibiotics marked a golden age in the revolution of human medicine. However,decades later, bacterial infections remain a global healthcare threat, and a return to the pre-antibiotic era seems inevitable if stringent measures are not adopted to curb the rapid emergence and spread of multidrug resistance and the indiscriminate use of antibiotics. In hospital settings, multidrug resistant(MDR) pathogens, including carbapenem-resistant Pseudomonas aeruginosa, vancomycin-resistant enterococci(VRE), methicillin-resistant Staphylococcus aureus(MRSA), and extendedspectrum β-lactamases(ESBL) bearing Acinetobacter baumannii, Escherichia coli, and Klebsiella pneumoniae are amongst the most problematic due to the paucity of treatment options,increased hospital stay, and exorbitant medical costs. Antimicrobial peptides(AMPs) provide an excellent potential strategy for combating these threats. Compared to empirical antibiotics, they show low tendency to select for resistance, rapid killing action, broad-spectrum activity, and extraordinary clinical efficacy against several MDR strains. Therefore, this review highlights multidrug resistance among nosocomial bacterial pathogens and its implications and reiterates the importance of AMPs as next-generation antibiotics for combating MDR superbugs. 展开更多
关键词 MULTIDRUG resistance NOSOCOMIAL INFECTIONS Antimicrobial peptide Antibiotic alternatives
下载PDF
Cyst(e)ine in nutrition formulation promotes colon cancer growth and chemoresistance by activating mTORCl and scavenging ROS 被引量:3
4
作者 Jiao Wu Sai-Ching Jim Yeung +12 位作者 Sicheng Liu Aiham Qdaisat Dewei Jiang Wenli Liu Zhuo Cheng Wenjing Liu Haixia Wang Lu Li Zhongmei Zhou Rong Liu Chuanyu Yang Ceshi Chen Runxiang Yang 《Signal Transduction and Targeted Therapy》 SCIE CSCD 2021年第6期1907-1919,共13页
Weight loss and cachexia are common problems in colorectal cancer patients;thus,parenteral and enteral nutrition support play important roles in cancer care.However,the impact of nonessential amino acid components of ... Weight loss and cachexia are common problems in colorectal cancer patients;thus,parenteral and enteral nutrition support play important roles in cancer care.However,the impact of nonessential amino acid components of nutritional intake on cancer progression has not been fully studied.In this study,we discovered that gastrointestinal cancer patients who received cysteine as part of the parenteral nutrition had shorter overall survival(P<0.001)than those who did not.Cystine indeed robustly promotes colon cancer cell growth in vitro and in immunodeficient mice,predominately by inhibiting SESN2 transcription via the GCN2-ATF4 axis,resulting in mTORCl activation.mTORCl inhibitors Rapamycin and Everolimus block cystine-induced cancer cell proliferation.In addition,cystine confers resistance to oxaliplatin and irinotecan chemotherapy by quenching chemotherapy-induced reactive oxygen species via synthesizing glutathione.We demonstrated that dietary deprivation of cystine suppressed colon cancer xenograft growth without weight loss in mice and boosted the antitumor effect of oxaliplatin.These findings indicate that cyst(e)ine;as part of supplemental nutrition,plays an important role in colorectal cancer and manipulation of cyst(e)ine content in nutritional formulations may optimize colorectal cancer patient survival. 展开更多
关键词 colon chemotherapy FORMULATION
原文传递
Glucose-6-phosphate dehydrogenase neutralizes stresses by supporting reductive glutamine metabolism and AMPK activation 被引量:1
5
作者 Benfu Zhong Dewei Jiang +7 位作者 Yang Hong Lifang Li Li Qiu Ronghui Yang Xiaohan Jin Yawen Song Ceshi Chen Binghui Li 《Signal Transduction and Targeted Therapy》 SCIE CSCD 2021年第3期580-583,共4页
Dear Editor,Glucose-6-phosphate dehydrogenase(G6PD)is the rate-limiting enzyme in the oxidative pentose phosphate pathway(oxPPP)that can generate cytosolic NADPH(Fig.1a)for biosynthesis and oxidative defence.Here,we r... Dear Editor,Glucose-6-phosphate dehydrogenase(G6PD)is the rate-limiting enzyme in the oxidative pentose phosphate pathway(oxPPP)that can generate cytosolic NADPH(Fig.1a)for biosynthesis and oxidative defence.Here,we reveal a previously unidentified function of G6PD.It,even the natural G6PD deficiency-associated mutant without the activity to maintain the normal oxPPP,can antagonize the stresses by supporting the reductive glutamine metabolism and AMPK activation,independently of the NADPH generation by the oxPPP. 展开更多
关键词 SUPPORTING REDUCTIVE OXIDATIVE
原文传递
Corrigendum to“SARS-CoV-2 induced intestinal responses with a biomimetic human gut-on-chip”[Sci.Bull.(2021)66(8)783-793] 被引量:4
6
作者 Yaqiong Guo Ronghua Luo +11 位作者 Yaqing Wang Pengwei Deng Tianzhang Song Min Zhang Peng Wang Xu Zhang Kangli Cui Tingting Tao Zhongyu Li Wenwen Chen Yongtang Zheng Jianhua Qin 《Science Bulletin》 SCIE EI CSCD 2021年第20期2144-2144,共1页
The authors would like to correct Fig.2g.An annotation error was introduced in the preparation of this figure for publication.The authors declare that this correction does not change the results or conclusions of this... The authors would like to correct Fig.2g.An annotation error was introduced in the preparation of this figure for publication.The authors declare that this correction does not change the results or conclusions of this paper.The authors sincerely apologize for having this error in the article,and apologize for any inconvenience caused. 展开更多
关键词 correction sincerely FIGURE
原文传递
仿生肠芯片研究新冠病毒诱发肠组织感染 被引量:3
7
作者 郭雅琼 罗荣华 +11 位作者 王亚清 邓鹏伟 宋天章 张敏 王鹏 张旭 崔康莉 陶婷婷 李中玉 陈雯雯 郑永唐 秦建华 《Science Bulletin》 SCIE EI CSCD 2021年第8期783-793,M0003,M0004,共13页
新型冠状病毒(SARS-CoV-2)引起的新冠肺炎(COVID-19)已导致全球大流行.临床发现,大量病人主要以呼吸道症状为主,但20%~50%的患者具有明显的胃肠道症状,包括腹痛、腹泻、便血,甚至肠道穿孔等,提示肠道有可能是新型冠状病毒攻击的另一个... 新型冠状病毒(SARS-CoV-2)引起的新冠肺炎(COVID-19)已导致全球大流行.临床发现,大量病人主要以呼吸道症状为主,但20%~50%的患者具有明显的胃肠道症状,包括腹痛、腹泻、便血,甚至肠道穿孔等,提示肠道有可能是新型冠状病毒攻击的另一个主要靶器官.本文利用器官芯片技术建立了一种包含多种类型细胞、组织-组织界面、细胞外基质和机械流体等复杂微环境因素的肠芯片装置.通过在芯片不同腔室内进行人肠上皮细胞(Caco-2)、黏液分泌细胞(HT-29)和人脐静脉内皮细胞(HUVECs)的三维(3D)动态共培养,在体外仿生构建了具有肠上皮-血管内皮界面特征的肠组织屏障,具有典型的肠绒毛结构、黏液分泌和屏障完整性等功能.进一步利用该芯片装置探究了SARSCo V-2感染对肠组织的影响.结果显示,病毒暴露后肠上皮细胞内可见大量病毒复制,同时出现明显的肠绒毛损伤,黏液分泌细胞分布异常,钙黏蛋白(E-cadherin)表达水平降低以及细胞形态异常等病理变化.此外,病毒感染还可导致血管内皮细胞损伤,包括细胞间连接蛋白(VE-cadherin)表达降低及细胞数量明显减少.以上证实SARS-Co V-2感染可破坏肠组织屏障功能.转录组分析发现,病毒感染可诱发人肠上皮细胞和血管内皮细胞的异常响应,包括免疫反应相关信号通路(如TNF和NF-kappa B)激活以及促炎细胞因子和趋化因子相关基因表达升高等(如TNF,IL-6和CXCL10),提示新冠病毒感染可导致肠道损伤和炎症反应.该工作首次利用肠芯片体系在组织水平反映新冠病毒感染导致的肠屏障损伤和一系列病理响应,为COVID-19机制、传播途径研究和药物评价等提供了新的策略和技术平台. 展开更多
关键词 促炎细胞因子 组织界面 病毒感染 肠组织 药物评价 形态异常 病毒复制 细胞外基质
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部